e-learning
resources
ERJ
2002
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Variability and lack of predictive ability of asthma end-points in clinical trials
Zhang J., Yu C., Holgate S.T., Reiss T.F.
Source:
Eur Respir J 2002; 20: 1102-1109
Journal Issue:
November
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zhang J., Yu C., Holgate S.T., Reiss T.F.. Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J 2002; 20: 1102-1109
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019
Relationship between omalizumab efficacy and baseline allergen profile impacts patient-reported outcomes in allergic asthma
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021
Clinical predictors of the effectiveness of tiotropium in adults with symptomatic asthma: the real-life data
Source: International Congress 2018 – Tests and trends in asthma
Year: 2018
Correlation of airway obstruction and patient-reported endpoints in clinical studies
Source: Eur Respir J 2001; 17: 220-224
Year: 2001
Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials
Source: Eur Respir J, 53 (5) 1900599; 10.1183/13993003.00599-2019
Year: 2019
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial
Source: Eur Respir J 2007; 30: 457-466
Year: 2007
Methacoline challenge response in controlled asthma and correlations with other disease characteristics
Source: Annual Congress 2012 - Asthma management
Year: 2012
Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults
Source: International Congress 2019 – Clinical implications of asthma management
Year: 2019
Clustering of adherence variability metrics and clinical outcomes in asthma
Source: International Congress 2018 – Clinical determinants of asthma and biomarkers
Year: 2018
Dupilumab improves patient-reported outcomes in uncontrolled persistent asthma patients with ongoing allergic rhinitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Patients’ perception of allergic asthma and their compliance to omalizumab in an Italian clinical setting
Source: International Congress 2017 – Asthma management
Year: 2017
Prevalence of altering selected spirometry maneuvers in asthma clinical trials.
Source: Virtual Congress 2021 – Future advances in respiratory physiology
Year: 2021
Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006
Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma.
Source: International Congress 2017 – Airway disease and exacerbations
Year: 2017
The clinical, spirometric and cytological profiles of exacerbations in poorly controlled severe persistent asthmatics
Source: Annual Congress 2007 - Towards controlling severe asthma
Year: 2007
Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Short-term and long-term reproducibility of non-invasive clinical and inflammatory parameters in asthma
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012
The ability of fluctuation analysis of airway function and symptoms to asses asthma stability in different asthma phenotypes
Source: Eur Respir J 2007; 30: Suppl. 51, 257s
Year: 2007
Can we predict response of refractory asthmatic cough to tiotropium? :a prospective study
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept